Blood Test to Predict Schizophrenia Shows Promise
By Carole Tanzer Miller HealthDay Reporter
TUESDAY, Feb. 13, 2024 — Researchers say they have developed a blood test for schizophrenia.
More than 3 million people in the United States have schizophrenia, a disorder marked by hallucinations and delusions, or a related psychotic illness.
The new test, which is expected to be available later this year from MindX Sciences, identifies markers in the blood that objectively measure a person's risk for schizophrenia, allowing doctors to tailor treatments to their individual biology.
"Schizophrenia is hard to diagnose, especially early on, and matching people to the right treatment from the beginning is very important," said senior study author Dr. Alexander Niculescu, a professor of psychiatry and medical neuroscience at Indiana University School of Medicine in Indianapolis.
"Psychosis usually manifests in young adulthood -- a prime period of life," he explained in a university news release. "Stress and drugs, including marijuana, are precipitating factors on a background of genetic vulnerability. If left unchecked, psychosis leads to accumulating biological damage, social damage and psychological damage."
His team published its research Feb. 8 in the journal Molecular Psychiatry.
For their study, they followed psychiatric patients for more than a decade, identifying biomarkers that predicted high rates of hallucination and delusions, as well as future related hospitalizations. They also examined which biomarkers were targets of existing drugs.
The work builds on previous studies by Niculescu, who is also a staff psychiatrist at the Veterans Administration Medical Center in Indianapolis, and his colleagues over the past two decades.
They have examined blood biomarkers for other psychiatric issues, including anxiety, post-traumatic stress disorder (PTSD), memory disorders and suicide risk.
In general, Niculescu said, the best biomarkers were better predictors than standard scales used to evaluate someone who has hallucinations or delusions.
"Fortunately, biologically some of the existing medications work quite well if initiated early in the right patients," he said. "Social support is also paramount, and once that and medications are in place, psychological support and therapy can help as well."
While Niculescu said there is still much to learn, there is reason for optimism in this era of emerging precision psychiatry.
Funding for the study was provided by the National Institutes of Health and the VA.
Sources
- Indiana University School of Medicine, news release, Feb. 8, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
In Experiments, Mice Got ill From Raw Milk Carrying Bird Flu Virus
FRIDAY, May 24, 2024 -- Confirming the dangers of drinking raw cow's milk when the H5N1 avian flu virus is circulating in U.S. dairy herds, researchers found that mice fed the...
FDA Panel Gives Nod to Blood Test for Colon Cancer
FRIDAY, May 24, 2024 -- A U.S. Food and Drug Administration advisory panel on Thursday recommended the approval of a new blood test that can spot colon cancer. The panel voted...
New Steps Towards a Male Birth Control Pill
FRIDAY, May 24, 2024 -- For decades, the responsibility for birth control has fallen largely on women, but new research suggests a birth control pill for men might one day become...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
